|
某三甲医院4年间脑卒中并发肺炎患者感染细菌分布及耐药性分析
|
Abstract:
目的:基于某医院抗菌药物耐药监测,分析调查脑卒中并发肺炎患者常见病原菌分布特征及抗菌药物使用情况。方法:使用来自广安某三甲医院4年间抗菌药物药敏试验记录进行横断面回顾性研究,对纳入统计的132株细菌药敏结果进行分析。结果:病原菌包括细菌及真菌,其中革兰氏阴性菌占比80.3%,主要为大肠埃希菌及肺炎克雷伯菌,大肠埃希菌和克雷伯菌中产ESBLs株,分别占11.1%和52.5%,革兰阳性菌中以葡萄球菌为主,暂未鉴定出肺炎链球菌。最常用的抗菌药物以头孢噻肟、哌拉西林/他唑巴坦及美罗培南为主,联合用药占比为60.8%,尚未发现耐碳青霉烯大肠埃希菌及肺炎克雷伯菌,未鉴定出铜绿假单胞菌粘菌素耐药株。结论:脑卒中并发肺炎感染病原菌是以大肠埃希菌及肺炎克雷伯菌为主的革兰阴性菌,临床应引起足够重视,规范临床合理使用抗菌药物,加强预防感染措施,减缓细菌耐药,促进患者预后的提高和整体医疗进步。
Objective: Based on the monitoring of antimicrobial resistance in a hospital, the distribution characteristics of common pathogenic bacteria and the use of antimicrobial agents in stroke patients complicated with pneumonia were analyzed and investigated. Methods: The results of antimicrobial susceptibility from a hospital in Guang’an in four years were retrospectively studied, and 132 strains of bacteria included in the statistics were analyzed. Results: Pathogens include bacteria and fungi, among which gram-negative bacteria account for 80.3%, mainly E. coli and K. pneumoniae. E. coli and K. pneumoniae produce ESBLs strains, accounting for 11.1% and 52.5% respectively. Staphylococcus is the main Gram-positive bacteria, and S. pneumoniae has not been found yet. The most commonly used antimicrobial agents are cefotaxime, piperacillin/tazobactam and meropenem, and the combined use of antimicrobial agents accounts for 60.8%. No carbapenem-resistant strains of Escherichia coli and Klebsiella pneumoniae have been found, and no colistin-resistant strains of Pseudomonas aeruginosa have been identified. Conclusion: E. coli and K. pneumoniae are the main pathogens of pneumonia infection in stroke patients, so we should pay enough attention to it in clinic, standardize the rational use of antibacterial drugs in clinic, strengthen infection prevention measures, slow down bacterial resistance, and promote the improvement of patients’ prognosis and overall medical progress.
[1] | 马风伟, 邓青芳. 缺血性脑卒中病理生理机制及治疗对策研究进展[J]. 贵州师范大学学报(自然科学版), 2022, 40(6): 116-122 |
[2] | Feigin, V.L., Stark, B.A., Johnson, C.O., Roth, G.A., Bisignano, C., Abady, G.G., et al. (2021) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820. https://doi.org/10.1016/s1474-4422(21)00252-0 |
[3] | 李卫征, 刘伟, 武国良, 等. 缺血性脑卒中患者并发肺部感染的病原学特点及危险因素分析[J]. 中国病原生物学杂志, 2023, 18(11): 1320-1323. |
[4] | 缪琪蕾, 莫丽亚, 王敏红. 脑卒中后并发肺部感染的危险因素分析[J]. 广西医学, 2014(4): 503-504. |
[5] | Green, T.L., McNair, N.D., Hinkle, J.L., Middleton, S., Miller, E.T., Perrin, S., et al. (2021) Care of the Patient with Acute Ischemic Stroke (Posthyperacute and Prehospital Discharge): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement from the American Heart Association. Stroke, 52, e179-e197. https://doi.org/10.1161/str.0000000000000357 |
[6] | 张爱莲, 柯慧, 陈夏, 等. 脑卒中肺部感染危险因素及血清免疫炎性因子的预测价值[J]. 中华医院感染学杂志, 2021, 31(6): 827-831. |
[7] | 赵丽娜, 雷贤英, 高晓岚, 等. ICU脑卒中相关性肺炎患者多药耐药菌感染的病原学特点及影响因素分析[J]. 中华医院感染学杂志, 2020, 30(1): 67-71. |
[8] | Quyet, D., Hien, N.M., Khan, M.X., Pham, D.D., Thuan, D.D., Dang, D.M., et al. (2019) Risk Factors for Stroke Associated Pneumonia. Open Access Macedonian Journal of Medical Sciences, 7, 4416-4419. https://doi.org/10.3889/oamjms.2019.873 |
[9] | 黄敬, 冯超, 李俊雯, 等. 急性非重症卒中相关性肺炎危险因素分析[J]. 同济大学学报(医学版), 2020, 41(3): 303-308. |
[10] | Driver, B.E., Prekker, M.E., Klein, L.R., Reardon, R.F., Miner, J.R., Fagerstrom, E.T., et al. (2018) Effect of Use of a Bougie vs Endotracheal Tube and Stylet on First-Attempt Intubation Success among Patients with Difficult Airways Undergoing Emergency Intubation: A Randomized Clinical Trial. JAMA, 319, 2179-2189. https://doi.org/10.1001/jama.2018.6496 |
[11] | 吴淑芳, 顾志贤, 芮雪, 等. 进展性脑卒中患者肺部感染危险因素及预防对策思考[J]. 解放军预防医学杂志, 2019, 37(11): 51-52. |
[12] | Liu, Y., Cao, Q. and Ma, B. (2019) Pathogens Distribution and Drug Resistance in Patients with Acute Cerebral Infarction Complicated with Diabetes and Nosocomial Pulmonary Infection. BMC Infectious Diseases, 19, Article No. 603. https://doi.org/10.1186/s12879-019-4142-9 |
[13] | 胡付品, 郭燕, 朱德妹, 等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2021, 21(4): 377-387. |
[14] | 商淑梅, 杨淑娴, 石金英, 等. 老年卒中相关性肺炎危险因素及病原菌耐药性分析[J]. 公共卫生与预防医学, 2022, 33(4): 137-140. |
[15] | 李虎, 孟保福. 老年卒中相关性肺炎并发多重耐药菌感染的病原菌分布及影响因素分析[J]. 中国药物滥用防治杂志, 2023, 29(10): 1723-1725, 1735. |
[16] | Meng, F., Cheng, J., Sang, P. and Wang, J. (2020) Effects of Bronchoalveolar Lavage with Ambroxol Hydrochloride on Treating Pulmonary Infection in Patients with Cerebral Infarction and on Serum Proinflammatory Cytokines, MDA and Sod. Computational and Mathematical Methods in Medicine, 2020, Article ID: 7984565. https://doi.org/10.1155/2020/7984565 |
[17] | Wang, X., Ma, L., Hu, X., Wang, K. and Cheng, J. (2020) Application of the Respiratory “Critical Care-Sub-Critical Care-Rehabilitation Integrated Management Model” in Severe Stroke Associated Pneumonia. BMC Pulmonary Medicine, 20, Article No. 61. https://doi.org/10.1186/s12890-020-1100-7 |
[18] | 尹莎莎, 戴月如, 修瑜, 等. 金黄色葡萄球菌毒力和耐药基因分布与耐药相关性分析[J]. 中国抗生素杂志, 2024, 49(2): 199-207. |
[19] | Zhang, S.R., Nold, M.F., Tang, S., Bui, C.B., Nold, C.A., Arumugam, T.V., et al. (2019) IL-37 Increases in Patients after Ischemic Stroke and Protects from Inflammatory Brain Injury, Motor Impairment and Lung Infection in Mice. Scientific Reports, 9, Article No. 6922. https://doi.org/10.1038/s41598-019-43364-7 |
[20] | 胡灿芳, 罗国君, 唐春雷, 等. 老年脑卒中后认知功能障碍合并肺部感染患者病原菌分布、炎症因子水平变化及危险因素分析[J]. 临床军医杂志, 2021, 49(1): 81-82. |
[21] | 王晶晶. 进展性脑卒中患者肺部感染危险因素分析[J]. 新乡医学院学报, 2022, 39(1): 85-87, 91. |
[22] | Jernigan, J.A., Hatfield, K.M., Wolford, H., Nelson, R.E., Olubajo, B., Reddy, S.C., et al. (2020) Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017. New England Journal of Medicine, 382, 1309-1319. https://doi.org/10.1056/nejmoa1914433 |